Lake Street Advisors Group LLC Buys 94 Shares of Agilent Technologies, Inc. (NYSE:A)

Lake Street Advisors Group LLC grew its stake in Agilent Technologies, Inc. (NYSE:A) by 2.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,295 shares of the medical research company’s stock after acquiring an additional 94 shares during the period. Lake Street Advisors Group LLC’s holdings in Agilent Technologies were worth $489,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Ballentine Partners LLC increased its position in Agilent Technologies by 7.7% in the third quarter. Ballentine Partners LLC now owns 2,732 shares of the medical research company’s stock worth $406,000 after purchasing an additional 195 shares during the period. DT Investment Partners LLC boosted its stake in shares of Agilent Technologies by 22.8% in the 3rd quarter. DT Investment Partners LLC now owns 737 shares of the medical research company’s stock valued at $109,000 after purchasing an additional 137 shares during the last quarter. Assenagon Asset Management S.A. grew its position in shares of Agilent Technologies by 173.6% during the 3rd quarter. Assenagon Asset Management S.A. now owns 27,113 shares of the medical research company’s stock worth $4,026,000 after buying an additional 17,203 shares during the period. Argent Capital Management LLC raised its stake in shares of Agilent Technologies by 2.5% during the third quarter. Argent Capital Management LLC now owns 29,927 shares of the medical research company’s stock worth $4,444,000 after buying an additional 728 shares during the last quarter. Finally, International Assets Investment Management LLC acquired a new position in Agilent Technologies in the third quarter valued at approximately $12,961,000. 87.42% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the transaction, the senior vice president now directly owns 40,011 shares in the company, valued at $5,801,595. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Agilent Technologies news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the sale, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Padraig Mcdonnell sold 1,958 shares of the company’s stock in a transaction on Thursday, August 22nd. The shares were sold at an average price of $145.00, for a total transaction of $283,910.00. Following the completion of the transaction, the chief executive officer now owns 24,118 shares in the company, valued at approximately $3,497,110. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,995 shares of company stock valued at $1,739,510 in the last three months. 0.33% of the stock is currently owned by corporate insiders.

Agilent Technologies Stock Performance

A opened at $130.19 on Friday. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The company has a market capitalization of $37.98 billion, a price-to-earnings ratio of 30.78, a P/E/G ratio of 6.96 and a beta of 1.05. The business’s 50-day moving average price is $140.53 and its two-hundred day moving average price is $138.43. Agilent Technologies, Inc. has a 1 year low of $96.80 and a 1 year high of $155.35.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, August 21st. The medical research company reported $1.32 EPS for the quarter, beating the consensus estimate of $1.26 by $0.06. The firm had revenue of $1.58 billion for the quarter, compared to analysts’ expectations of $1.56 billion. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business’s quarterly revenue was down 5.6% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.43 EPS. Equities analysts expect that Agilent Technologies, Inc. will post 5.24 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were given a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a yield of 0.73%. The ex-dividend date of this dividend was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is currently 22.22%.

Analysts Set New Price Targets

Several brokerages have commented on A. TD Cowen upped their target price on shares of Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Citigroup increased their target price on Agilent Technologies from $150.00 to $165.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. Barclays boosted their target price on Agilent Technologies from $135.00 to $145.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 15th. Evercore ISI increased their price target on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a research report on Tuesday, October 1st. Finally, Wells Fargo & Company initiated coverage on shares of Agilent Technologies in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $157.00 target price for the company. One research analyst has rated the stock with a sell rating, five have issued a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $144.36.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.